EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The 2023 ACR/ EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease

Abhishek Abhishek, Sara K Tedeschi iD, Tristan Pascart iD, Augustin Latourte iD, Nicola Dalbeth iD, Tuhina Neogi iD, Amy Fuller, Ann Rosenthal iD, Fabio Becce iD, Thomas Bardin iD, Hang Korng Ea iD, Georgios Filippou iD und 45 weitere

Arthritis & Rheumatology · 2023-10 · 75 (10) · 1703-1713

DOI: 10.1002/art.42619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 26.07.2023. Verfasst von Abhishek Abhishek und 56 weiteren Autor:innen. Beteiligte Einrichtung: Academic Rheumatology, University of Nottingham, Nottingham, UK. Hauptthemen laut MEDLINE: Calcinosis, Calcium Pyrophosphate, Chondrocalcinosis, Rheumatology. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Calcium pyrophosphate deposition (CPPD) disease is prevalent and has diverse presentations, but there are no validated classification criteria for this symptomatic arthritis. The American College of Rheumatology (ACR) and EULAR have developed the first‐ever validated classification criteria for symptomatic CPPD disease.

Methods

Supported by the ACR and EULAR, a multinational group of investigators followed established methodology to develop these disease classification criteria. The group generated lists of candidate items and refined their definitions, collected de‐identified patient profiles, evaluated strengths of associations between candidate items and CPPD disease, developed a classification criteria framework, and used multi‐criterion decision analysis to define criteria weights and a classification threshold score. The criteria were validated in an independent cohort.

Results

Among patients with joint pain, swelling, or tenderness (entry criterion) whose symptoms are not fully explained by an alternative disease (exclusion criterion), the presence of crowned dens syndrome or calcium pyrophosphate crystals in synovial fluid are sufficient to classify a patient as having CPPD disease. In the absence of these findings, a score >56 points using weighted criteria, comprising clinical features, associated metabolic disorders, and results of laboratory and imaging investigations, can be used to classify as CPPD disease. These criteria had a sensitivity of 92.2% and specificity of 87.9% in the derivation cohort (190 CPPD cases, 148 mimickers), whereas sensitivity was 99.2% and specificity was 92.5% in the validation cohort (251 CPPD cases, 162 mimickers).

Conclusion

The 2023 ACR/EULAR CPPD disease classification criteria have excellent performance characteristics and will facilitate research in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalcinosisCalcium PyrophosphateChondrocalcinosisRheumatologyHumansSyndromeUnited States

Substanzen

Calcium Pyrophosphate

Autor:innen und Institutionen

  • Academic Rheumatology, University of Nottingham, Nottingham, UK.
  • Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.
  • Department of Rheumatology, Lille Catholic University, Saint-Philibert Hospital, Lille, France.
  • Université de Paris, INSERM, UMR-S 1132 BIOSCAR, and Service de Rhumatologie, AP-HP, Lariboisière Hospital, Paris, France.
  • Department of Medicine, University of Auckland, Auckland, New Zealand.
  • Department of Medicine, Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts.

ORCID-Profile: Sara K Tedeschi, Tristan Pascart, Augustin Latourte, Nicola Dalbeth, Tuhina Neogi, Ann Rosenthal, Fabio Becce, Thomas Bardin, Hang Korng Ea, Georgios Filippou, John FitzGerald, Roberta Ramonda, Mariano Andres, Edoardo Cipolletta, Lisa K Stamp, Uri Arad, Alessandra Bortoluzzi, Carlo Scirè, Silvia Sirotti, Chio Yokose, William J Taylor

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Abhishek, A., Tedeschi, S. K., Pascart, T., Latourte, A., Dalbeth, N., Neogi, T., Fuller, A., Rosenthal, A., Becce, F., Bardin, T., Ea, H. K., Filippou, G., FitzGerald, J., Iagnocco, A., Lioté, F., McCarthy, G. M., Ramonda, R., Richette, P., Sivera, F., …, & Choi, H. K. (2023). The 2023 ACR/ EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease. Arthritis & Rheumatology, 75(10), 1703-1713. https://doi.org/10.1002/art.42619

Vancouver

Abhishek A, Tedeschi SK, Pascart T, Latourte A, Dalbeth N, Neogi T, et al. The 2023 ACR/ EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease. Arthritis & Rheumatology. 2023;75(10):1703-1713. doi:10.1002/art.42619

BibTeX
@article{Abhishek2023,
  author = {Abhishek, Abhishek and Tedeschi, Sara K and Pascart, Tristan and Latourte, Augustin and Dalbeth, Nicola and Neogi, Tuhina and Fuller, Amy and Rosenthal, Ann and Becce, Fabio and Bardin, Thomas and Ea, Hang Korng and Filippou, Georgios and FitzGerald, John and Iagnocco, AnnaMaria and Lioté, Frédéric and McCarthy, Geraldine M and Ramonda, Roberta and Richette, Pascal and Sivera, Francisca and Andres, Mariano and Cipolletta, Edoardo and Doherty, Michael and Pascual, Eliseo and Perez-Ruiz, Fernando and So, Alexander and Jansen, Tim L and Kohler, Minna J and Stamp, Lisa K and Yinh, Janeth and Adinolfi, Antonella and Arad, Uri and Aung, Thanda and Benillouche, Eva and Bortoluzzi, Alessandra and Dau, Jonathan and Maningding, Ernest and Fang, Meika A and Figus, Fabiana A and Filippucci, Emilio and Haslett, Janine and Janssen, Matthijs and Kaldas, Marian and Kimoto, Maryann and Leamy, Kelly and Navarro, Geraldine M and Sarzi-Puttini, Piercarlo and Scirè, Carlo and Silvagni, Ettore and Sirotti, Silvia and Stack, John R and Truong, Linh and Xie, Chen and Yokose, Chio and Hendry, Alison M and Terkeltaub, Robert and Taylor, William J and Choi, Hyon K},
  title = {The 2023 ACR/ EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease},
  journal = {Arthritis & Rheumatology},
  year = {2023},
  volume = {75},
  number = {10},
  pages = {1703--1713},
  doi = {10.1002/art.42619}
}
Kostenlos starten →